BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1144761)

  • 21. Cellular hypersensitivity in patients with adenomatous hyperplasia and adenocarcinoma of the endometrium.
    Chen SY; Cohen CJ; Koffler D
    Am J Obstet Gynecol; 1976 Oct; 126(3):370-3. PubMed ID: 986771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.
    Walewski J; Nowakowska A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):29-33. PubMed ID: 7283677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peripheral T-lymphocytes and delayed hypersensitivity in surgically and radiologically treated patients with early stages of larynx-carcinoma].
    Behrens K; Sesterhenn K; Schütt A
    HNO; 1982 Jul; 30(7):250-5. PubMed ID: 6981631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No difference in delayed hypersensitivity between breast and cervical carcinomas.
    Munzarová M; Kovarík J; Ptácková B; Hlávková J; Kolcová V; Nebeský T
    Neoplasma; 1984; 31(1):95-8. PubMed ID: 6700799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
    Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
    J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer.
    Halili MR; Spigland I; Foster N; Ghossein NA
    J Surg Oncol; 1978; 10(5):457-63. PubMed ID: 215844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Delayed hypersensitivity intracutaneous test with dinitrochlorobenzene (DNCB)].
    Grigorovich NA; Martysiuk TI; Monastyrnaia PL
    Vopr Onkol; 1979; 25(7):94-5. PubMed ID: 483690
    [No Abstract]   [Full Text] [Related]  

  • 29. Proton radiation therapy.
    Archambeau JO; Bennett GW; Levine GS; Cowen R; Akanuma A
    Radiology; 1974 Feb; 110(2):445-57. PubMed ID: 4203944
    [No Abstract]   [Full Text] [Related]  

  • 30. DNCB and PPD skin testing in breast cancer.
    Munzarová M; Kovarík J; Ninger E; Zemanová D; Lauerová L; Kolcová V; Hlávková J; Pacovský Z
    Neoplasma; 1983; 30(4):385-9. PubMed ID: 6888607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB; Catalona WJ; Twomey PL; Sample WF
    Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor spread and reactivity to DNCB: (2, 4 Dinitro-1 chlorobenzene) skin test.
    el-Domeiri AA
    Int Surg; 1972 Aug; 57(8):617-9. PubMed ID: 5051760
    [No Abstract]   [Full Text] [Related]  

  • 35. Investigations on general immune reactivity in untreated cervical cancer patients.
    Micksche M; Luger T; Michalica W; Tatra G
    Oncology; 1978; 35(5):206-9. PubMed ID: 724199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiation-related eosinophilia. Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapy.
    Ghossein NA; Bosworth JL; Stacey P; Muggia FM; Krishnaswamy V
    Radiology; 1975 Nov; 117(2):413-7. PubMed ID: 1178876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin reactivity to dinitrochlorobenzene in cancer patients.
    Jassem J; Serkies K
    Neoplasma; 1980; 27(5):589-93. PubMed ID: 7231615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
    Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
    Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of murine tumors upon delayed hypersensitivity to dinitrochlorobenzene. III. In vivo activity of the nonspecific suppressor cell.
    Jessup JM; Macek CM; Kahan BD; Pellis NR
    J Immunol; 1981 Nov; 127(5):2183-7. PubMed ID: 6457866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.